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OBJECTIVE — We evaluated the efﬁcacy of malabsorptive bariatric surgery on daily blood
glucose ﬂuctuations and oxidative stress in type 2 diabetic obese patients.
RESEARCH DESIGN AND METHODS — The 48-h continuous subcutaneous glucose
monitoring was assessed in type 2 diabetic patients before and 1 month after biliopancreatic
diversion (BPD) (n  36), or after diet-induced equivalent weight loss (n  20). The mean
amplitude of glycemic excursions and oxidative stress (nitrotyrosine) were evaluated during
continuous subcutaneous glucose monitoring. During a standardized meal, glucagon-like pep-
tide (GLP)-1, glucagon, and insulin were measured.
RESULTS — Fasting and postprandial glucose decreased equally in surgical and diet groups.
AmarkedincreaseinGLP-1occurredduringtheinterprandialperiodinsurgicalpatientstoward
the diet group (P  0.01). Glucagon was more suppressed during the interprandial period in
surgical patients compared with the diet group (P  0.01). Mean amplitude of glycemic excur-
sions and nitrotyrosine levels decreased more after BPD than after diet (P  0.01).
CONCLUSIONS — Oxidative stress reduction after biliopancreatic diversion seems to be
related to the regulation of glucose ﬂuctuations resulting from intestinal bypass.
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C
ogent evidence suggests that acute
ﬂuctuations of glucose around a
mean value over a daily period of
intermittent hyperglycemia and obe-
sity, activating oxidative stress, might
playanimportantroleincardiovascular
diseaseintype2diabeticpatients(1–3).
As a consequence, it is strongly sug-
gested that a global antidiabetic strategy
should be aimed at reducing the differ-
ent components of dysglycemia (A1C,
fasting and postprandial glucose, and
glucose variability). Although improve-
ments in glycemic control have been
observed in subjects with type 2 diabe-
tes after malabsorptive bariatric surgery
(4),therearenostudiesthathaveexam-
ined the surgery effects on the glucose
ﬂuctuations over a daily period and on
oxidativestressproduction.Becausethe
regulation strategy of daily glucose ﬂuc-
tuations attempts to normalize incretin
secretions over a daily period (5), this
study was conducted to evaluate the ef-
ﬁcacy of biliopancreatic diversion
(BPD), as malabsorptive bariatric sur-
gery, on glucagon-like peptide (GLP)-1
and glucagon as well as on oxidative
stress activation (nitrotyrosine) and
daily blood glucose ﬂuctuations during
continuous subcutaneous glucose mon-
itoring in type 2 diabetic obese patients.
RESEARCH DESIGN AND
METHODS— A total of 56 obese type
2 diabetic patients (BMI 40 kg/m
2), el-
igible candidates for BPD, not on insulin,
exenatide, or dipeptidyl peptidase 4 in-
hibitors, were studied. All participants
signed an informed consent, approved by
our institution. One group was studied
before and 1 month after GBP (surgical
group,n36).Asecondgroup,fulﬁlling
thesamerecruitmentcriteria,wasstudied
before and after a 10-kg diet-induced
weight loss (diet group, n  20). All par-
ticipants have voluntarily chosen to un-
dergo to surgery or dietary intervention.
In the diet group, the mean recom-
mended daily caloric intake was 1,100
kcal (from 1,050 to 1,250 kcal). The rec-
ommendeddietaryregimenwas55%car-
bohydrates, 30% lipid, and 15% protein,
and this regimen was followed on an out-
patient basis until 10-kg weight loss. The
surgical group had undergone BPD that
was performed as previously described
(6). All patients received the same paren-
teral nutrition regimen (1,400 kcal/day)
during the ﬁrst 6 days after surgery; then
the same daily caloric intake of the diet
group was recommended. Continuous
subcutaneous glucose monitoring mea-
surements (Glucoday, Menarini, Italy)
were monitored, over a period of 3 con-
secutive days, at baseline and within 1
month after surgery in the surgical group
andaftera10-kgdiet-inducedweightloss
in the diet group. The mean amplitude of
glycemic excursions (MAGE), which has
been described by Service et al. (7), was
used for assessing glucose ﬂuctuations
during the fasting plasma glucose (FPG),
postprandial plasma glucose (PPG), diur-
nal and nocturnal interprandial periods
on study days 1 and 2. Standardized meal
tests with 24-h sampling comprising
three mixed meals were performed on
days 1, 2, and 3 (breakfast: 310 kcal;
lunch: 440 kcal; dinner: 350 kcal). Dur-
ing the standardized meal, glucose,
GLP-1 (enzyme-linked immunosorbent
assay [ELISA], D.B.A., Santa Cruz Bio-
technology, Milan, Italy), glucagon
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and insulin (Ares, Serono, Italy) were eval-
uated at the following times: 0, 60, 120,
180, 240, and 300 min, with the meal be-
ginning immediately after time 0 and con-
sumed within 15 min. Nitrotyrosine (anti-
nitrotyrosine rabbit polyclonal antibody;
D.B.A., Santa Cruz Biotechnology) (8) was
assessedatbaselineandafter1monthin
the surgical group and after a 10-kg di-
et-induced weight loss in the diet
group. A P value 0.05 deﬁned as sta-
tistical signiﬁcance. Simple Pearson
correlation was used to assess linear re-
lationships between single variables.
RESULTS— Atbaseline,patientswere
matched for anthropometric, physical ac-
tivity, metabolic, and hormonal variables
(Table 1) . Duration of weight loss was
shorter for the surgical group (30.2 
11.9 days) than the diet group (60.2 
10.1 days; P  0.001). BMI, A1C, FPG,
and PPG decreased signiﬁcantly and
equally in surgical and diet groups (Table
1). Despite similar data in A1C, FPG, and
PPGduringweightlossinthesurgicaland
diet groups, pattern of daily glucose ﬂuc-
tuations (MAGE) improved after BPD
(P  0.01), but not in the diet group,
despite a similar weight loss (Table 1).
Focusing on hormone proﬁles during a
standard meal and interprandial periods,
one can highlight that increase in GLP-1
after food intake was substantially identi-
cal in the two groups, whereas a signiﬁ-
cant (P  0.05) and sustained increase
duringtheinterprandialperiod(from120
to300minafterameal)ofactiveGLP-1in
Table 1—Clinical characteristics and metabolic proﬁle before and after 1 month after biliopancreatic diversion or 10-kg weight loss
Biliopancreatic diversion group
P
Diet group
P Baseline After 1 month Baseline
After 10-kg
weight loss
Age (years) 45  8— — 4 6  6— —
Male/female sex (n) 16/20 16/20 — 9/11 9/11 —
BMI (kg/m
2) 43.7  2.9 39.1  3.2 0.01 43.6  3.1 38.9  3.3 0.01
Systolic blood pressure (mmHg) 120  12 119  13 NS 121  13 120  10 NS
Diastolic blood pressure (mmHg) 79  57 8  3N S 8 0  47 9  3N S
Diabetes duration (years) 3.2  4 — — 3.1  6— —
Risk factors
Hypertension 9 (25) — — 5 (25) — —
Hypercholesterolemia 4 (11) — — 2 (10) — —
Smokers 4 (11) — — 2 (10) — —
Laboratory
Fasting glycemia (mg/dl) 129  19 109  12 0.01 128  13 106  14 0.01
2-h postprandial glycemia (mg/dl) 186  23 164  16 0.01 185  21 165  15 0.01
A1C (%) 7.1  0.4 6.8  0.3 0.01 7.0  0.5 6.6  0.4 0.01
MAGE (mg/dl glucose) 61  13 35  12* 0.01 60  21 55  14 NS
Nitrotyrosine (mol/l) 0.81  0.04 0.44  0.03* 0.01 0.79  0.03 0.76  0.06 NS
Fasting insulin (pmol/l) 170  55 131  48 0.01 178  68 127  50 0.01
Postmeal insulin AUC (pmol/l) 498  179 669  135 0.01 505  157 655  122 0.01
Interprandial insulin AUC
(pmol   l
1   min
1) 325  124 290  108 0.01 339  111 301  122 0.01
Fasting glucagon (ng/l) 71.9  12 65.3  11.6 NS 69.9  13 66.2  11 NS
Postmeal glucagon AUC (ng/l) 68.3  14 50  9 0.01 66.7  10 53  12 0.01
Interprandial glucagon AUC
(ng   l
1   min
1) 70.7  13 53.6  12* 0.01 69.3  12 68.6  13 NS
Fasting GLP-1 (pmol/l) 6.5  1.2 7.1  1.1 NS 6.6  1.8 6.9  1.5 NS
Postmeal GLP-1 AUC (pmol/l) 9.9  2.1 18.7  3.2 0.01 10.2  2.9 19.3  2.6 0.01
Interprandial GLP-1 AUC
(pmol   l
1   min
1) 6.2  1.1 11.7  2.5* 0.01 6.5  1.3 7.2  1.4 NS
Active therapy
ACE inhibitors 5 (14) 5 (14) — 3 (15) 3 (15) —
Angiotensin II antagonists 4 (11) 4 (11) — 2 (10) 2 (10) —
Diuretics 4 (11) 4 (11) — 2 (10) 2 (10) —
Aspirin 10 (28) 10 (28) — 6 (30) 6 (30) —
Statins 8 (22) 8 (22) — 5 (25) 5 (25) —
Metformin 32 (89) 32 (89) — 18 (90) 18 (90) —
Thiazolinediones 10 (28) 10 (28) — 6 (30) 6 (30) —
Data are means  SD or n (%) unless otherwise indicated. Postmeal (0–120 min) and interprandial (120–300 min after meal) areas under the curve (AUCs) for
outcome variables were calculated using the trapezoidal method. *P  0.05 compared with the diet group. Nitrotyrosine was assayed as described previously (8):
the standard curve was constructed with serial dilution of a nitrated protein solution; the limit of detection of the assay was 10 nmol/l, with intra- and interassay
coefﬁcients of variation of 4.5 and 8%, respectively.
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1). In addition, plasma glucagon levels
were more suppressed during the inter-
prandial period in surgical patients com-
pared with diet patients (Table 1), but
such differences did not reach statistical
signiﬁcance during the postprandial pe-
riod. Finally, both fasting and postmeal
plasma insulin level changes were similar
inthetwogroups(Table1).Nitrotyrosine
levels were signiﬁcantly lower after BPD
compared with diet (P  0.01) (Table 1).
Interestingly enough, nitrotyrosine reduc-
tions were directly related to MAGE
changesinthesurgerygroup(r0.55,P
0.01). Moreover, MAGE changes were di-
rectly related to interprandial GLP-1 in-
creases (r  0.45, P  0.01). Finally, the
GLP-1 changes were inversely correlated
withtheglucagonchanges(r0.42,P
0.01) and directly correlated with insulin
changes (r  0.52, P  0.01).
CONCLUSIONS — BPD, when per-
formedinobesediabeticpatients,iseffec-
tive in improving glycemic control (6). In
this study, the efﬁcacy of BPD on A1C,
FPG, and PPG reductions was compara-
ble to the diet intervention. Nevertheless,
our study shows evidence that the effects
of BPD on daily glucose ﬂuctuations, as
estimatedfromMAGEindexesthatreﬂect
both upward and downward glucose
changes, were more pronounced in the
BPD group than in the diet group, which
could be due to different effects on incre-
tin secretion. Although the well-matched
surgical and diet groups lost the same
amount of weight, their changes in incre-
tin levels were strikingly different. Ac-
cording to the previous data (9,10), both
GLP-1 and glucagon responses to stan-
dardized meals markedly increased 1
month after BPD and 10-kg diet-induced
weight loss, without signiﬁcant differ-
ences among the groups. However, BPD
patients showed a signiﬁcantly better
daily GLP-1 and glucagon proﬁles in in-
terprandial periods, which could be re-
sponsible for a MAGE within a shorter
range. From a more practical point of
view, since BPD, by blunting the daily
ﬂuctuations of glucose, is associated with
a reduction of oxidative stress, the malab-
sorptive surgery may have an important
role not only in the normalization of gly-
cemic variability but also in reducing the
impact of diabetes in vascular health.
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